期刊文献+

脓毒症患者行局部枸橼酸抗凝持续肾脏替代治疗过程中钙的管理 被引量:3

Calcium management during continuous renal replacement therapy with regional citrate anticoagulation in patients with sepsis
原文传递
导出
摘要 脓毒症是指机体对感染的宿主反应失调导致的威胁生命的器官功能障碍[1]。CRRT是ICU中治疗脓毒症的重要措施之一。它可以改善脓毒症患者的器官功能,精确控制体液平衡,清除炎症介质等[2-5]。合理的抗凝剂和抗凝方法是确保CRRT顺利进行的重要部分。2012年肾病改善全球预后(KDIGO)临床实践指南建议,无论患者的出血风险和凝血状态如何,只要患者没有枸橼酸使用禁忌证,枸橼酸是行CRRT患者的首选抗凝剂[6]。 Sepsis is one of the most common fatal diseases in intensive care unit(ICU).If left untreated,sepsis may develop into severe sepsis,multiple organ dysfunction syndrome or even death.Continuous renal replacement therapy(CRRT)is an important method for the treatment of sepsis.Currently,regional citrate anticoagulation(RCA)is the preferred anticoagulation method for CRRT,among which ionic calcium([iCa])plays a key role.The disorder of calcium metabolism is associated with poor outcomes in patients with sepsis,so it is essential to maintain the balance of ion calcium in the body.This paper reviews the latest research results and clinical practice of calcium management in patients with sepsis undergoing regional citrate anticoagulation continuous renal replacement therapy(RCA-CRRT),in order to improve the level of understanding of blood purification therapy in patients with sepsis.
作者 程晓红 魏宁 邵义明(审校) CHENG Xiaohong;WEI Ning;SHAO Yiming
出处 《临床急诊杂志》 CAS 2021年第11期779-784,共6页 Journal of Clinical Emergency
关键词 脓毒症 持续肾脏替代治疗 局部枸橼酸抗凝 sepsis calcium continuous renal replacement therapy regional citrate anticoagulation
  • 相关文献

参考文献9

二级参考文献59

  • 1叶朝阳,付文成,戎殳,陈静,张斌,梅长林.高浓度枸橼酸钠应用于含钙透析液行常规血液透析37例临床分析[J].中国实用内科杂志,2005,25(4):362-363. 被引量:14
  • 2张淑文,苏强,王超,阴赪宏,王红,王宝恩.脓毒性休克患者的病死率和危险因素研究[J].创伤外科杂志,2007,9(1):8-10. 被引量:15
  • 3刘宏宝,陈威,王汉民,刘晓渭,许国双,张鹏,白淑蓉,于艳.不同血液滤过置换液对创伤后多器官功能障碍综合征糖代谢障碍患者的疗效比较[J].中华急诊医学杂志,2007,16(12):1243-1247. 被引量:3
  • 4Heleen M Oudemans- van Straaten, John A Kellum, Rinaldo Bello- nan. Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate[ J]. Crit Care,2011,15 ( 1 ) :202.
  • 5Louise Schilder, S Azam Nurmohamed, Frank H Bosch, et al. Citrate anticoagulation versus systemic heparinisation in continuous veno- venous hemofiltration in critically ill patients with acute kidney inju- ry:a multi-center randomized clinical trial [ J]. Crit Care, 2014, 18 (4) : 472.
  • 6Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A recta-analysis of randomized controlled trials. Am J Kidney Dis 2012;59:810-8. doi: 10.1053/j.ajkd.2011.11.030.
  • 7van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996;7:145-50.
  • 8Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126 3 Suppl: 311S-37S. doi: 10.1378/chest.126.3_suppl.311s.
  • 9KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138. doi: 10.1038/ kisup.2012.
  • 10Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium. Clin Chem Lab Med 2006;44:962-6. doi: 10.1515/cclm.2006.164.

共引文献72

同被引文献35

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部